TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
RGEN

Repligen Corporation

Healthcare · Medical Instruments & Supplies

184.50$ -1.2% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Repligen Corporation (RGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,950 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RGEN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
285 289 291 309 734 120 743 745 762 139 798 1,068 1,379 1,400 1,406 1,442 1,476 1,903 1,927 2,016 2,241 2,358 2,384 2,445 2,463 2,532 2,538 2,549 2,514 2,831 2,849 2,862 2,831 2,830 2,852 2,902 2,924 2,950 2,931 2,950
220 184 186 196 231 243 248 253 267 276 284 316 622 642 651 687 697 902 926 984 911 932 945 976 953 998 1,019 999 978 1,111 1,133 1,159 1,132 1,066 1,032 1,057 1,096 1,137 1,161 1,201
158 142 130 142 160 174 174 176 190 194 196 209 513 528 530 560 553 717 711 734 621 604 585 597 573 523 517 604 631 751 781 809 784 757 697 709 749 566 583 607
179 142 142 145 160 174 174 176 190 194 196 209 513 528 530 560 553 717 711 734 621 604 585 597 573 624 618 604 631 751 781 809 784 757 697 709 749 768 785 810
15 16 18 23 30 28 29 32 31 36 39 44 43 44 45 49 56 71 90 103 122 117 122 121 118 116 133 120 106 124 116 123 129 134 147 157 149 159 152 158
24 25 24 26 39 39 40 41 42 42 45 51 52 55 62 70 79 95 110 136 156 184 214 239 243 238 245 241 211 202 198 191 182 143 153 156 160 170 179 187
15 15 15 16 22 22 23 24 29 32 35 38 43 48 50 52 55 67 72 136 155 125 148 168 174 191 193 325 – – – – – – – – – – – –
31 60 60 61 327 327 328 327 327 327 326 470 469 468 468 469 482 618 618 618 834 860 859 854 851 856 856 871 869 987 986 986 988 1,031 1,082 1,114 1,113 1,114 1,107 1,104
19 30 29 29 147 145 142 139 137 135 133 220 216 213 209 205 215 287 282 277 340 337 330 322 360 361 347 352 344 407 388 380 381 398 409 406 395 386 368 358
119 120 114 118 157 152 146 146 156 159 173 189 334 340 337 342 351 374 371 413 526 608 617 640 627 621 598 578 526 866 879 876 814 857 867 840 841 844 825 838
20 21 14 17 118 25 20 121 130 130 130 141 39 48 42 44 51 319 313 332 349 375 424 424 411 404 405 374 363 165 178 174 108 127 152 123 131 136 126 133
– 95 96 97 98 99 100 101 102 103 108 109 3.0 3.6 3.7 4.0 4.5 249 250 254 258 264 293 295 297 292 293 288 289 75 79 82 12 15 15 16 19 22 21 19
5.1 5.1 4.6 7.0 6.4 7.3 6.2 6.7 9.5 10 9.8 11 10.0 11 10 14 14 17 21 25 28 36 38 40 25 28 26 24 19 20 19 21 21 32 27 26 29 30 35 33
94 95 96 97 0.0 99 100 0.0 0.0 – 17 – 230 233 235 238 241 – – – – – – – – – – – – 510 514 518 522 526 530 534 538 542 547 551
167 -60 177 191 577 -32 597 599 606 616 625 879 1,045 1,060 1,070 1,100 1,125 1,529 1,556 1,603 1,715 1,750 1,766 1,805 1,835 1,911 1,940 1,971 1,989 1,965 1,971 1,986 2,017 1,973 1,985 2,062 2,083 2,106 2,105 2,112
-65 -60 -57 -48 -44 -32 -29 -26 -21 -16 -7.5 0.6 2.2 5.8 16 32 46 66 95 131 165 194 258 308 349 397 426 446 464 433 441 444 441 407 413 428 443 456 465 470
34 34 34 35 43 44 44 45 46 46 46 49 52 53 53 53 53 55 57 57 57 58 59 57 57 57 57 57 57 56 57 56 57 56 57 57 57 57 57 57

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?